Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

The Problem With Our Boost-Boost-Boost COVID Strategy

Por: The Atlantic Opinion October 27, 2022

thumbnail

We need to explore more options for fighting the disease, but our leaders lack moral imagination.Prabin Ranabhat / GettyOctober 27, 2022, 9:40 AM ETThe United States has defaulted to treating life with the coronavirus as the , but this normal, sadly, is anything but new. Americans have always lived with deadly inequities in our society, and we can’t seem to imagine doing better. For the past six months, the U.S. has averaged 300 to 500 COVID... + full article



Similar News

Novavax Covid-19 Booster Gets FDA Authorization, Does This Deserve More Attention?

Forbes USA Tech October 22, 2022

thumbnailThe U.S. Food and Drug Administration (FDA) has just extended the emergency use authorization (EUA) ... [+] for Novavax’s adjuvanted (NVX-CoV2373) Covid-19 vaccine to now include a first booster dose for those 18 years and older. (Photo by Matt McClain/The Washington Post via... + más

FDA Authorizes Novavax's Covid Shots as Mix-And-Match Booster to Pfizer Or Moderna | NBC 6 South Florida

FDA authorizes Novavax's Covid shots as mix-and-match booster to Pfizer or Moderna | CNBC


Council Post: B2B Full-Funnel Marketing, Part Two: Strategy, Tactics And C-Suite Buy-In

Forbes USA Business October 19, 2022

thumbnailAlex Macura is the founder and CMO of . A full-funnel agency that supports online businesses with their digital growth. getty As a B2B marketer, I know what unique battles you face. I’ve been doing this for decades, and I have to say that in my experience, it doesn’t really... + más

Digital payments: Which industries would benefit the most? | Business Insider

Influencer marketing stats: How creators have impacted businesses in 2021 | Business Insider


What you need to know about long COVID

Portland Press Herald USA Health October 14, 2022

thumbnailNearly three years into the coronavirus pandemic, the long-lasting consequences of COVID-19 are becoming more evident. What we don’t know: the exact causes of long COVID. What we don’t have: a test to diagnose the condition. Most people who develop COVID recover quickly, but... + más

Dreaded Side Effect Rears Its Ugly Head in Latest COVID Variant | The Daily Beast

New guidance released on diagnosing, treating long COVID symptoms | ABC News


US sees ‘decisive decade’ ahead in competition with China, Russia

Fox Business USA Business October 13, 2022

thumbnailRep. Mark Green, R-Tenn., joined 'Kennedy' to discuss Russian President Vladimir Putin's upcoming meeting with Chinese President Xi Jinping in Uzbekistan.  The U.S. is entering a decisive decade as it confronts both its competition with China and a Russia... + más

Russia, China deepen relations with shared anti-U.S. goal: NATO official | Newsweek

Japanese leader's trip to China in '72 was diplomatic gamble | WPLG Local 10


The Do’s And Don’t Of Investing For Retirement

Forbes USA Business October 06, 2022

thumbnailWhat are the do's and don't of investing when you're preparing for retirement? (Photo by Scott ... [+] Olson)Getty Images Whether you’re handling your investments on your own or working with a firm to handle them, it’s a good idea to understand what goes into... + más

Hurricane Ian Reminds Us Of 3 Retirement Risks Few Consider | Forbes

Silicon Valley VC has been investing in climate tech for a decade — here's what he's into now | CNBC


New guidance released on diagnosing, treating long COVID symptoms

ABC News USA Health September 29, 2022

thumbnailCiting concerns about the lingering and sometimes debilitating long-term impacts of on the body -- and observed inequities amongst minority patients suffering disproportionately from the virus -- medical experts on “” issued the first guidance of its kind to diagnose and... + más

How to kick antidepressant drugs without triggering a relapse: new research | Newsweek

Dreaded Side Effect Rears Its Ugly Head in Latest COVID Variant | The Daily Beast


Dreaded Side Effect Rears Its Ugly Head in Latest COVID Variant

The Daily Beast USA World September 22, 2022

thumbnailAll over the world, the rates of death and hospitalization from keep dropping. But our successful mitigation of the worst outcomes of the 33-month-old pandemic belie a growing crisis.More and more people are surviving COVID and staying out of the hospital, but more and more... + más

Mystery as to why new COVID variants have stalled in growth | ABC News

Hundreds of Americans still dying of COVID-19 each day ahead of the fall | ABC News



About iurex | Privacy Policy | Disclaimer |